Vásquez Krisly Arguedas, Valverde Erick Miranda, Aguilar Daniel Valerio, Gabarain Henri-Jacques Hernández
Geriatrician-Gerontologist Hospital Carlos Luis Valverde Vega, Caja Costarricense de Seguro Social, Alajuela, Costa Rica.
Geriatrician-Gerontologist Memory Clinic, National Hospital of Geriatrics and Gerontology, Caja Costarricense de Seguro Social, San José, Costa Rica.
Dement Neuropsychol. 2019 Jan-Mar;13(1):78-81. doi: 10.1590/1980-57642018dn13-010008.
Several screening tests have been used for cognitive evaluation in Parkinson's disease (PD).
To evaluate the usefulness of the Montreal Cognitive Assessment (MoCA) in patients with Parkinson's disease and no cognitive impairment complaints.
A total of 40 PD patients with no complaints of cognitive problems were included. Patients were selected using the Mini-Mental State Examination (MMSE) and the MoCA was then administered.
80% of patients exhibited Mild Cognitive Impairment (MCI) according to the MoCA. Statistically significant differences in visuospatial, attention and delayed recall functions were evident between the normal and abnormal MoCA groups.
The study results suggest that MoCA may be a good screening test in patients with PD who do not present cognitive complaints.
几种筛查测试已用于帕金森病（PD）的认知评估。
评估蒙特利尔认知评估量表（MoCA）在无认知障碍主诉的帕金森病患者中的效用。
共纳入40例无认知问题主诉的帕金森病患者。通过简易精神状态检查表（MMSE）筛选患者，然后进行MoCA测试。
根据MoCA评估，80%的患者存在轻度认知障碍（MCI）。MoCA正常组与异常组在视觉空间、注意力和延迟回忆功能方面存在显著统计学差异。
研究结果表明，MoCA可能是一种适用于无认知主诉的帕金森病患者的良好筛查测试。
